Opulence Capital Management
O2330-2350 KLGQ Building Masdar City, Abu Dhabi, United Arab Emirates
Overview
An Opulence Group company - Opulence Capital Management provides capital management, project finance, financial and sovereign advisory, development and project management and other services supporting the project lifecycle through our group affiliates. Our strong capital backing and international team as part of the Opulence Group, allow us an unparalleled ability to utilize our global resources to help our clients and governments around the world to develop their projects completely turnkey - with OCM team taking ideas from pre-concept to completion and delivery by structuring every component required - from finance, to insurance, project management, and all pitfalls in the way of project delivery. With subsidiaries with roots established in the emerging markets since 1972, our diverse and experienced global team have delivered, through different aspects of the project ecosystem, some of the most ambitious projects and financings for the Eastern world including such hallmarks as Burj Khalifa, the Makkah-Madinah Railway Project, advisement on the setup of several prominent regional and sovereign wealth funds in the GCC and Asia, groundbreaking infrastructure in ASEAN, and several of the defining projects of the 21st century in our core markets. OCM's team, spread throughout six continents and thirteen offices, through which we cover capital markets in the West and our client base throughout the Middle East, Africa, and Asia, hail from all the corners of the globe and promote our diversity. We believe that through our development leading standards of transparency, Anti-Money Laundering Compliance, and anti-corruption policies, management and efforts we affect a positive change on the ecosystems we operate within. OCM's mission to provide substantial increase in the development and flow of resources to the emerging and growth markets is marked by centuries of combined team experience. For more information on OCM and Opulence Group, please visit our website.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- Nano Cures
Led · Equity · Mar 2021
Nano Cures has developed a Cures Platform and novel self‑administered delivery technology that moves beyond syringes to nasal, dermal, ophthalmic, sub‑lingual, and oral options. The company is focused on scaling its platform for COVID-19 variants, including vaccines and persistent immunity delivery. Nano plans to open the Cures Platform to other pharmaceutical companies and their vaccines to enable broader dose delivery. Management says the funds will accelerate global scale-up and regional expansion efforts. The company is accelerating plans to bring the platform to emerging regions such as the GCC, Southeast Asia, Latin America and Central/Southern Europe. Nano is also developing universal pan‑coronavirus vaccines and therapeutics for annual protection against known and emerging coronaviruses.
Team
No current team members are available.